On Monday, Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million. According to ...
Following a 2023 data breach and a bankruptcy and sale process in 2025, the genetic testing company 23andMe will pay $6 ...
SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. ("23andMe" or the "Company") (OTC: MEHCQ), a genetics-led consumer healthcare company, today announced that it has received ...
Customers who have purchased services from 23andMe may be eligible to receive up to $10,000 from the company's settlement. Personal genomics and biotechnology company 23andMe's settlement in a ...
SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered ...
Me researchers analyzed results for nearly 6 million research-consented U.S. participants who received FDA-authorized Genetic Health Risk reports between 2017 and 2025. The reports cover 91 variants ...
After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy Wojcicki has started out hot with an opening bid nearly $50 million higher ...
Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she co-founded nearly 20 years ago, has received the court greenlight. That means Wojcicki’s nonprofit TTAM Research Institute will ...
Add Yahoo as a preferred source to see more of our stories on Google. Close-up of collection kit for personal genomics technology company 23AndMe on a retail store shelf, March 18, 2019. (Courtesy of ...